Ann: Trading Halt, page-239

Hi Tangentland :

Your recent post led me to look back at my early accumulation of NEU, usually buying on the dips. NEU's consolidation lowered the number of shares but not the quality of the research & development, the pharmaceutical targets, the management team, and of course potential returns for the shareholders. I continued to accumulate after consolidation and covered my investment costs by selling a parcel when the SP rose (prudent management for audited SMSF).

Settlement Date Buy/ Sell Security
27/05/2005 B NEU
19/04/2006 B NEU
28/09/2006 B NEU
6/11/2006 B NEU
6/02/2007 B NEU
9/08/2007 B NEU
1/02/2008 B NEU
19/07/2011 B NEU
27/11/2013 B NEU
ETC...ETC..

I'm delighted with the progress made by the NEU team and trust their judgement and actions are in the interests of all shareholders, & ultimately will be of benefit to patients. That's my story : I expect others will be different but some might be similar...to each one I wish 'good luck' !

Not professional advice : Pls do your own DD